Can circulating biomarkers identify heart failure patients at low risk?

被引:4
|
作者
Richards, A. Mark [1 ,2 ]
Frampton, Chris M. [1 ]
机构
[1] Univ Otago, Christchurch Heart Inst, Christchurch 8014, New Zealand
[2] Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore
关键词
PRESERVED EJECTION FRACTION; EMERGENCY-DEPARTMENT; DIAGNOSTIC PROTOCOL; SERUM GALECTIN-3; CHEST-PAIN; TRIAL; HOSPITALIZATION;
D O I
10.1002/ejhf.438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1213 / 1215
页数:3
相关论文
共 50 条
  • [41] CT-HF score: how to identify heart failure patients with low risk of coronary artery disease
    Pries-Heje, M. M.
    Hasselbalch, R. B.
    Engstroem, T.
    Sandoe, A.
    Heitman, M.
    Pedersen, F.
    Schou, M.
    Mickley, H.
    Elming, H.
    Steffensen, R.
    Koeber, L.
    Iversen, K. K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1110 - 1110
  • [42] An Individualized, Alert-based Heartlogic Management Strategy Can Identify Patients At Risk For Impending Heart Failure Events
    Vigdor, Aaron
    Lin, David
    Yaeger, Amaryah
    Birati, Edo Y.
    Mazurek, Jeremy A.
    Prenner, Stuart
    Goldberg, Lee R.
    Tanna, Monique S.
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S43 - S43
  • [43] Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH
    Meijers, Wouter C.
    de Boer, Rudolf A.
    van Veldhuisen, Dirk J.
    Jaarsma, Tiny
    Hillege, Hans L.
    Maisel, Alan S.
    Di Somma, Salvatore
    Voors, Adriaan A.
    Peacock, W. Frank
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (12) : 1271 - 1282
  • [44] Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?
    Rahbar, Habib
    Parsian, Sana
    Lam, Diana L.
    Dontchos, Brian N.
    Andeen, Nicole K.
    Rendi, Mara H.
    Lehman, Constance D.
    Partridge, Savannah C.
    CLINICAL IMAGING, 2016, 40 (01) : 125 - 129
  • [45] The Utility of Circulating and Imaging Biomarkers Alone and in Combination in Heart Failure
    Jaltotage, Biyanka
    Dwivedi, Girish
    Ooi, Daryl Eng Lee
    Mahadavan, Gnanadevan
    CURRENT CARDIOLOGY REVIEWS, 2021, 17 (05)
  • [46] Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure
    Qaisar, Rizwan
    Karim, Asima
    Muhammad, Tahir
    Shah, Islam
    Khan, Javaidullah
    GLOBAL HEART, 2021, 16 (01)
  • [47] Can the Presence of Atrial Fibrillation Influences the Levels of Heart Failure - Specific Biomarkers in Overweight and Obese Patients with Heart Failure?
    Dadarlat, Alexandra
    Pop, Dana
    Farcas, Anca Daniela
    Zdrenghea, Dumitru
    Bodizs, Gyorgy
    Tomoaia, Raluca
    Gurzu, Diana
    Susca-Hojda, Silvana
    Tringu, Florina
    Buzoianu, Anca Dana
    REVISTA DE CHIMIE, 2019, 70 (06): : 2294 - 2299
  • [48] Circulating exosomes may identify biomarkers for cows at risk for metabolic dysfunction
    Fatema B. Almughlliq
    Yong Q. Koh
    Hassendrini N. Peiris
    Kanchan Vaswani
    Olivia Holland
    Susanne Meier
    John R. Roche
    Chris R. Burke
    Mallory A. Crookenden
    Buddhika J. Arachchige
    Sarah Reed
    Murray D. Mitchell
    Scientific Reports, 9
  • [49] Circulating exosomes may identify biomarkers for cows at risk for metabolic dysfunction
    Almughlliq, Fatema B.
    Koh, Yong Q.
    Peiris, Hassendrini N.
    Vaswani, Kanchan
    Holland, Olivia
    Meier, Susanne
    Roche, John R.
    Burke, Chris R.
    Crookenden, Mallory A.
    Arachchige, Buddhika J.
    Reed, Sarah
    Mitchell, Murray D.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [50] Use of the Valsalva manoeuvre to identify haemodialysis patients at risk of congestive heart failure
    van Kraaij, DJW
    Schuurmans, MMJ
    Jansen, RWMM
    Hoefnagels, WHL
    Go, RIH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (06) : 1518 - 1523